In the production of budesonide enteric capsules, precise micro-pellet filling and reliable capsule sealing are critical steps to ensure dose uniformity and the integrity of the enteric barrier. These two processes directly determine whether the final product can safely reach the intestine and release the drug accurately at the target site.


Accurately filling micro-pellets—coated with three functional sustained-release layers—into hard capsules is the core step in controlling the final dosage. The CAP Series Hard Capsule Filling Machine provides an efficient and highly precise solution for this application.
Its optional dedicated micro-pellet filling station offers the following advantages:
Flexible Changeover:
Micro-pellet and powder filling stations can be quickly exchanged without repeated disassembly of the drive system, supporting efficient multi-product manufacturing.
Gentle Handling:
A pusher-plate filling mechanism with a short stroke and low applied force is used to minimize abrasion of the pellet coating. Wear of the sustained-release layer is kept below 0.2%, effectively preserving the drug release profile.
High Dosing Accuracy:
Equipped with adjustable dosing molds offering up to a 60% adjustment range, the system flexibly accommodates different fill weights, with fill weight deviation consistently controlled within ±2%.
Smooth Material Flow:
The dosing plate can be optionally fitted with a vibration device to effectively eliminate pellet bridging and electrostatic adhesion, ensuring a continuous and stable filling process.
After filling, the capsules must be sealed. Beyond improving appearance, sealing is essential to ensure tight capsule closure during subsequent enteric coating, transportation, and storage—preventing moisture ingress or content leakage.
Canaan NSF800 Capsule Sealing Machine provides reliable performance for this process:

The combination of precise micro-pellet filling and reliable capsule sealing provides dual protection for both content uniformity and capsule shell integrity in budesonide enteric capsules. Through highly automated and refined equipment solutions, a solid foundation is established for the large-scale, high-quality production of this advanced dosage form.
Canaan Solid Dosage Form R&D Center is equipped with a complete testing platform covering laboratory-scale to pilot-scale studies, offering customers:
✅ Development and parameter optimization of enteric coating processes for hard capsules
✅ Integrated process testing to ensure seamless interfacing between Fluid-bed micro-pellet drug layering and capsule filling operations
Process solutions based on real production cases, helping shorten customer project timelines.




Batch-to-batch variability and low tablet production yields remain persistent challenges in solid dosage manufacturing. When inconsistencies arise, manufacturers often focus on excipient selection or process parameter adjustments. In many cases, the underlying issue is in the selection of the granulation process itself. This article explores Canaan’s granulation solutions for different material characteristics and process requirements, […]

Quick Answer Continuous manufacturing pharmaceutical systems merge blending, granulation, and compression into one unbroken line to meet GMP compliance under 21 CFR Part 11. These lines run in-line, real-time quality monitoring instead of end-of-batch testing, typically handling 5 to 40 kg per hour. Canaan’s integrated pharmaceutical continuous manufacturing lines are built to meet these standards, […]

Quick Answer Cleaning validation in pharmaceutical manufacturing is the documented proof that equipment meets a set residue limit every time. A validated wash runs pre-rinse, detergent wash, rinse, and dry stages under fixed time, temperature, and pressure parameters. Canaan’s QD Series washing stations combine automated washing and drying in one controlled cycle, with key process […]